Safety and Clinical Outcomes of Rituximab Treatment in Patients with Multiple Sclerosis and Neuromyelitis Optica: Experience from a National Online Registry (GRAID)

Registers of multiple sclerosis in Denmark

(2015) N. Koch-Henriksen et al.   ACTA NEUROLOGICA SCANDINAVICA

The off-label use of targeted therapies in sarcomas: the OUTC’S program

(2014) Lauriane Eberst et al.   BMC CANCER

Neuromyelitis optica: clinical features, immunopathogenesis and treatment

(2014) S. Jarius et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Rituximab Use in Pediatric Central Demyelinating Disease

(2014) Shannon J. Beres et al.   PEDIATRIC NEUROLOGY

B cells in MS and NMO: pathogenesis and therapy

(2014) Markus Krumbholz et al.   Seminars in Immunopathology

Therapeutic Plasma Exchange in Glucocorticosteroid-Unresponsive Patients With Clinically Isolated Syndrome

(2014) Johannes Ehler et al.   THERAPEUTIC APHERESIS AND DIALYSIS

Requirement for safety monitoring for approved multiple sclerosis therapies: an overview

(2013) P. S. Rommer et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Management of Secondary Progressive Multiple Sclerosis: Prophylactic Treatment—Past, Present, and Future Aspects

(2013) Paulus S. Rommer et al.   Current Treatment Options in Neurology

Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS)

(2013) Corinna Trebst et al.   JOURNAL OF NEUROLOGY

Immunopathogenic mechanisms of systemic autoimmune disease

(2013) Marie Wahren-Herlenius et al.   LANCET

A 5-Year Follow-up of Rituximab Treatment in Patients With Neuromyelitis Optica Spectrum Disorder

(2013) Su-Hyun Kim et al.   JAMA Neurology

Monoclonal Antibodies in the Treatment of Neuroimmunological Diseases

(2012) Paulus S. Rommer et al.   CURRENT PHARMACEUTICAL DESIGN

Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients

(2012) Sven Jarius et al.   Journal of Neuroinflammation

Immune-mediated CNS diseases: A review on nosological classification and clinical features

(2011) Uwe K. Zettl et al.   AUTOIMMUNITY REVIEWS

Rituximab for Secondary Progressive Multiple Sclerosis

(2011) Paulus S. Rommer et al.   CNS DRUGS

Long-term follow-up of patients with neuromyelitis optica after repeated therapy with rituximab

(2011) H. L. Pellkofer et al.   NEUROLOGY

Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID)

(2011) Hans-Peter Tony et al.   ARTHRITIS RESEARCH & THERAPY

MS and the B cell controversy

(2010) Anne H. Cross et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

The Potential Role of B Cell-Targeted Therapies in Multiple Sclerosis

(2010) Aaron Boster et al.   DRUGS

Rituximab add-on therapy for breakthrough relapsing multiple sclerosis: A 52-week phase II trial

(2010) R. T. Naismith et al.   NEUROLOGY

Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial

(2009) Kathleen Hawker et al.   ANNALS OF NEUROLOGY

Treatment of Neuromyelitis Optica With Rituximab

(2008)   ARCHIVES OF NEUROLOGY

Multiple sclerosis

(2008) Alastair Compston et al.   LANCET

B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis

(2008) Stephen L. Hauser et al.   NEW ENGLAND JOURNAL OF MEDICINE